China has officially become the second country in the world—after the United States—to develop and approve a homegrown nine-valent human papillomavirus (HPV) vaccine, marking a pivotal moment in global efforts to combat cervical cancer. The new vaccine, known as Cecolin 9, was developed by researchers from Xiamen University in collaboration with the Xiang An Biomedicine […]
